Keyphrases
Etiology
100%
Vascular Complications
100%
Preeclampsia
100%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
100%
Heme oxygenase-1 (HO-1)
57%
Soluble Endoglin
42%
Smokers
28%
Carbon Dioxide
28%
Inflammation
14%
MRNA Expression
14%
Statins
14%
Protective Behavior
14%
Therapeutic Intervention
14%
Cardiovascular Drugs
14%
Clinical Signs
14%
Normal Pregnancy
14%
Antiangiogenic Factors
14%
Severity of Preeclampsia
14%
Circulating Levels
14%
Placental Explants
14%
Clinical Onset
14%
Anti-inflammatory Molecules
14%
Cigarette Smoke Extract
14%
Chorionic Villus Sampling
14%
Early-onset Preeclampsia
14%
Preeclampsia Pathogenesis
14%
Incidence of Preeclampsia
14%
Biochemistry, Genetics and Molecular Biology
Heme Oxygenase
100%
Endoglin
75%
Enzyme
25%
Metabolite
25%
Messenger RNA
25%
Explant
25%
Statin
25%
Medicine and Dentistry
Pre-Eclampsia
100%
Heme Oxygenase 1
36%
Endoglin
27%
Carbon Monoxide
18%
Messenger RNA
9%
In Vitro
9%
Anti-Inflammatory Drug
9%
Cardiovascular Agent
9%
Antiangiogenic
9%
Statin
9%
Metabolite
9%
Cigarette Smoke
9%
Angiogenic Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Preeclampsia
100%
Heme Oxygenase 1
36%
Endoglin
27%
Carbon Monoxide
18%
Inflammation
9%
Messenger RNA
9%
Anti-Inflammatory Drug
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Cardiovascular Agent
9%
Antiangiogenic
9%
Angiogenic Factor
9%
Cigarette Smoke
9%